Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Q3 2025 value amounting to 0.4.

  • Rhythm Pharmaceuticals' Asset Utilization Ratio rose 3128.8% to 0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4, marking a year-over-year increase of 3128.8%. This contributed to the annual value of 0.36 for FY2024, which is 6579.08% up from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Asset Utilization Ratio of 0.4 as of Q3 2025, which was up 3128.8% from 0.41 recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Asset Utilization Ratio registered a high of 0.41 during Q2 2025, and its lowest value of 0.0 during Q1 2021.
  • Over the past 5 years, Rhythm Pharmaceuticals' median Asset Utilization Ratio value was 0.13 (recorded in 2023), while the average stood at 0.17.
  • As far as peak fluctuations go, Rhythm Pharmaceuticals' Asset Utilization Ratio surged by 1359257.0% in 2022, and later soared by 1303.48% in 2025.
  • Over the past 5 years, Rhythm Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then skyrocketed by 565.26% to 0.06 in 2022, then skyrocketed by 268.16% to 0.23 in 2023, then soared by 52.74% to 0.34 in 2024, then rose by 15.12% to 0.4 in 2025.
  • Its Asset Utilization Ratio stands at 0.4 for Q3 2025, versus 0.41 for Q2 2025 and 0.35 for Q1 2025.